초록접수 현황
| 17F-077 | 구연 미채택시 포럼 발표 |
Simultaneous Surgery of Concomitant Malignant Disease in the Esophagus and Lung
Jae Jun Jung, Sumin shin, Jong Ho Cho, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Jae Ill Zo, Young Mog Shim
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Purpose : The purpose of this study is to determine the risk and feasibility of simultaneous surgery in patients with concomitant malignant disease in the esophagus and lungs.
Methods : We retrospectively reviewed the charts of all our patients with concomitant malignant disease in the esophagus and lungs who received simultaneous surgical resection between from July 2002 to June 2017. The grade of complication was based on the Clavien-Dindo classification.
Results : A total of 23 patients underwent simultaneous surgical resection of concomitant malignant disease in the esophagus and lungs. The median age was 67 (24 men, 100%). The type of surgery about esophagus included Ivor Lewis operation (n=14), 3-hole operation (n=3), 3-field lymph node dissection (n=2), ECJ (3), Transhiatal (n=1). The extent of surgery about lung included bilobectomy (n=2), lobectomy (n=15), segmentectomy (n=2) and wedge resection (n=4). The type of thoracic approach included right thoracotomy only (n=15), left thoracotomy only (n=5), bilateral thoracotomy (n=1), right-robotic and left-VATS (n=1), left VATS only (n=1). 14 patients had at least one complication 56.5% (13/23). Total number of complication was 19. Grade I, II, III, and IV complication comprised 0% (0/19), 63.2% (12/19), 31.6% (6/19), and 0% (0/19) of all complication. Overall mortality rate (grade V) was 4.3% (1/23). Pulmonary complication were the most common complications (52.6%, 10/19), followed by esophagus related complication (21.0%, 4/19) and cardiovascular complication (15.8%, 3/19).
Conclusion : Simultaneous surgical resection of concomitant malignant disease in the esophagus and lungs is feasible in selected patients who have received careful preoperative evaluation, well planned surgical approach.
Methods : We retrospectively reviewed the charts of all our patients with concomitant malignant disease in the esophagus and lungs who received simultaneous surgical resection between from July 2002 to June 2017. The grade of complication was based on the Clavien-Dindo classification.
Results : A total of 23 patients underwent simultaneous surgical resection of concomitant malignant disease in the esophagus and lungs. The median age was 67 (24 men, 100%). The type of surgery about esophagus included Ivor Lewis operation (n=14), 3-hole operation (n=3), 3-field lymph node dissection (n=2), ECJ (3), Transhiatal (n=1). The extent of surgery about lung included bilobectomy (n=2), lobectomy (n=15), segmentectomy (n=2) and wedge resection (n=4). The type of thoracic approach included right thoracotomy only (n=15), left thoracotomy only (n=5), bilateral thoracotomy (n=1), right-robotic and left-VATS (n=1), left VATS only (n=1). 14 patients had at least one complication 56.5% (13/23). Total number of complication was 19. Grade I, II, III, and IV complication comprised 0% (0/19), 63.2% (12/19), 31.6% (6/19), and 0% (0/19) of all complication. Overall mortality rate (grade V) was 4.3% (1/23). Pulmonary complication were the most common complications (52.6%, 10/19), followed by esophagus related complication (21.0%, 4/19) and cardiovascular complication (15.8%, 3/19).
Conclusion : Simultaneous surgical resection of concomitant malignant disease in the esophagus and lungs is feasible in selected patients who have received careful preoperative evaluation, well planned surgical approach.
첨부파일 : Table.docx
책임저자: Young Mog Shim
Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
발표자: Jae Jun Jung, E-mail : adonismind@naver.com